Cetera Investment Advisers Has $5.92 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

Cetera Investment Advisers trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.7% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 18,436 shares of the company’s stock after selling 317 shares during the period. Cetera Investment Advisers’ holdings in HCA Healthcare were worth $5,923,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in HCA Healthcare by 0.4% during the first quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock valued at $5,666,569,000 after acquiring an additional 60,304 shares during the period. Wellington Management Group LLP boosted its holdings in HCA Healthcare by 1.7% during the fourth quarter. Wellington Management Group LLP now owns 10,186,129 shares of the company’s stock valued at $2,757,181,000 after acquiring an additional 170,560 shares during the period. Royal Bank of Canada lifted its stake in shares of HCA Healthcare by 35.7% in the fourth quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock valued at $1,219,121,000 after buying an additional 1,183,890 shares during the period. Capital World Investors lifted its stake in shares of HCA Healthcare by 57.5% in the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after buying an additional 1,019,750 shares during the period. Finally, Royal London Asset Management Ltd. lifted its stake in shares of HCA Healthcare by 11.9% in the fourth quarter. Royal London Asset Management Ltd. now owns 1,474,238 shares of the company’s stock valued at $399,047,000 after buying an additional 156,757 shares during the period. 62.73% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts recently weighed in on HCA shares. Barclays increased their target price on shares of HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a research note on Wednesday, July 24th. Leerink Partners increased their price target on shares of HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Oppenheimer increased their price target on shares of HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Finally, StockNews.com raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. Five investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $359.89.

Insider Transactions at HCA Healthcare

In related news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the sale, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the sale, the senior vice president now owns 17,755 shares in the company, valued at $6,303,912.75. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 17,202 shares of company stock valued at $6,407,273 over the last three months. 1.60% of the stock is currently owned by corporate insiders.

HCA Healthcare Price Performance

Shares of HCA stock opened at $382.41 on Tuesday. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $409.42. The stock has a market cap of $100.16 billion, a PE ratio of 19.06, a PEG ratio of 1.52 and a beta of 1.67. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. The firm’s 50 day moving average price is $384.62 and its two-hundred day moving average price is $345.72.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same period last year, the firm posted $4.29 earnings per share. As a group, analysts forecast that HCA Healthcare, Inc. will post 22.46 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, September 30th. Stockholders of record on Monday, September 16th were given a dividend of $0.66 per share. The ex-dividend date was Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.69%. HCA Healthcare’s dividend payout ratio is 13.16%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.